Kirin Holdings Net Long-Term Debt 2012-2025 | KNBWY
Kirin Holdings annual/quarterly net long-term debt history and growth rate from 2012 to 2025. Net long-term debt can be defined as the net amount of long term debt issued and repaid. This field is either calculated as the sum of the long term debt fields or used if a company does not report debt issued and repaid separately
- Kirin Holdings net long-term debt for the quarter ending September 30, 2025 was $-0.165B, a 75.53% increase year-over-year.
- Kirin Holdings net long-term debt for the twelve months ending September 30, 2025 was $0.616B, a 755.7% decline year-over-year.
- Kirin Holdings annual net long-term debt for 2024 was $1.181B, a 13.84% increase from 2023.
- Kirin Holdings annual net long-term debt for 2023 was $1.037B, a 455.61% increase from 2022.
- Kirin Holdings annual net long-term debt for 2022 was $0.187B, a 207.95% decline from 2021.
|
Kirin Holdings Annual Net Long-Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $1,181 |
| 2023 | $1,037 |
| 2022 | $187 |
| 2021 | $-173 |
| 2020 | $831 |
| 2019 | $-82 |
| 2018 | $-631 |
| 2017 | $-771 |
| 2016 | $-1,112 |
| 2015 | $522 |
| 2014 | N/A |
| 2013 | N/A |
| 2012 | N/A |
| 2011 | N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Consumer Staples | Alcoholic Beverages | $13.529B | $16.277B |
| Kirin Holdings Company, Limited is engaged in the manufacture and sale of alcohol beverages and soft drinks. The Company has four segments: Alcohol Beverage segment, Beverage and Food segment, Pharmaceutical and Biochemicals segment and Others segment. It offers beer, wine, ready-to-drink products, spirits, coffee, black tea, Japanese tea, mineral water, juices, dairy products and beverages, seasonings, soft drinks, freeze-dried soups, milk, and cheese. Kirin also engages in the research, development, manufacture and sale of various pharmaceutical products, manufacture and sale of diagnostic reagents, production and maintenance of genetically modified cattle and the research and development of human polyclonal antibody platform technology. Kirin Holdings Company, Limited, formerly known as Kirin Brewery Company, is headquartered in Tokyo, Japan. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anheuser-Busch (BUD) | Belgium | $147.711B | 20.30 |
| Ambev S.A (ABEV) | Brazil | $50.267B | 19.94 |
| Heineken (HEINY) | Netherlands | $46.023B | 0.00 |
| Diageo (DEO) | United Kingdom | $43.110B | 0.00 |
| Constellation Brands Inc (STZ) | United States | $28.812B | 14.07 |
| Pernod Ricard SA (PRNDY) | France | $19.248B | 0.00 |
| Carlsberg AS (CABGY) | Denmark | $18.118B | 0.00 |
| Brown Forman (BF.A) | United States | $13.624B | 17.27 |
| Brown-Forman (BF.B) | United States | $13.527B | 17.15 |
| Campari Group (DVDCF) | Italy | $9.727B | 0.00 |
| Tsingtao Brewery (TSGTY) | China | $8.724B | 0.00 |
| Molson Coors Beverage (TAP) | United States | $8.466B | 8.30 |
| Boston Beer (SAM) | United States | $2.687B | 26.41 |
| Remy Cointreau (REMYY) | France | $2.414B | 0.00 |
| Compania Cervecerias Unidas, S.A (CCU) | Chile | $2.317B | 18.72 |
| Agencia Comercial Spirits (AGCC) | Taiwan | $0.505B | 0.00 |
| MGP Ingredients (MGPI) | United States | $0.401B | 6.68 |
| Crimson Wine Group (CWGL) | United States | $0.091B | 147.81 |
| Epsium Enterprise (EPSM) | China | $0.018B | 0.00 |
| Willamette Valley Vineyards (WVVI) | United States | $0.012B | 0.00 |
| Innovation Beverage Group (IBG) | Australia | $0.001B | 0.00 |
| Vina Concha Y Toro (VCOYY) | Chile | $0.000B | 0.00 |